Gonadal function and puberty assessment in a cohort of Spanish pediatric survivors of childhood cancer

Endocrinologist

Volumn 19, Issue 3, 2009, Pages 133-141

  Martín, Itziar ^a,c   Valls, Carme ^a   Pavía, Carles ^b   Callejo, Justo ^a   Estella, Jesús ^a   Cruz, Ofelia ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b Hospital de Nens   (Spain)

^c CAP La Mina   (Spain)

Author keywords

Childhood cancer; Gonadal toxicity; Inhibin B; Late effects; Pubertal disorders

Indexed keywords

ESTRADIOL; FOLLITROPIN; INHIBIN B; LUTEINIZING HORMONE; TESTOSTERONE;

ACUTE LEUKEMIA; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DELAYED PUBERTY; GONAD FUNCTION; HISTIOCYTOSIS X; HUMAN; MAJOR CLINICAL STUDY; NEPHROBLASTOMA; NEUROBLASTOMA; PRESCHOOL CHILD; SCHOOL CHILD;

EID: 67651071982     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/TEN.0b013e3181a46acc     Document Type: Article

References (41)

1. Peris Bonet R, García Cano A, Muñoz Viera F, et al. Cáncer infantil en España. Estadísticas 1980-2006. Registro Nacional de Tumores Infantiles (RNTI-SEOP). Valencia, Spain: Universitat de València, CD-ROM; 2007.
2. Peris-Bonet R, Sánchez de Toledo J, González C, et al. Childhood cancer survival in five autonomous regions of Spain: data from the National Childhood Cancer Registry of the Spanish Society of Pediatric Oncology. Eur J Cancer. 2001;37(suppl 2):77-126.
3. Hudson MM, Mertens AC, Yasui Y, et al. Health status of adult long-term survivors of childhood cancer: a report from the Childhood Cancer Survivor Study. JAMA. 2003;290:1583-1592. (Pubitemid 37430383)
4. Oeffinger KC, Hudson MM. Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors. CA Cancer J Clin. 2004;54:208-236.
5. Brougham MF, Wallace WH. Subfertility in children and young people treated for solid and haematological malignancies. Br J Haematol. 2005;131:143-155.
6. Gleeson HK, Shalet SM. Endocrine complications of neoplastic diseases in children and adolescents. Curr Opin Pediatr. 2001;13:346-351. (Pubitemid 32701865)
7. Meistrich ML, Vassilopoulou-Sellin R, Lipshultz LI. Gonadal dysfunction. In: Devita VT Jr, Hellman S, Rosenberg SA. Cancer: Principles and Practice of Oncology. Philadelphia: Lippincot Williams and Wilkins; 2004:2923-2938.
8. Andersson AM, Skakkebaek NE. Serum inhibin B levels during male childhood and puberty. Mol Cell Endocrinol. 2001;180:103-107. (Pubitemid 32645634)
9. Andersson AM, Müller J, Skakkebaek NE. Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels. J Clin Endocrinol Metab. 1998;83:4451-4458. (Pubitemid 29100151)
10. Jensen TK, Andersson AM, Hjollund NH, et al. Inhibin B as a serum marker of spermatogenesis: correlation to differences in sperm concentration and follicle-stimulating hormone levels: a study of 349 Danish men. J Clin Endocrinol Metab. 1997;82:4059-4063.
11. Crofton PM, Evans AE, Groome NP, et al. Dimeric inhibins in girls from birth to adulthood: relationship with age, pubertal stage, FSH and estradiol. Clin Endocrinol (Oxf). 2002;56:223-230. (Pubitemid 34233960)
12. Foster CM, Phillips DJ, Wyman T, et al. Changes in serum inhibin, activin, and follistatin concentrations during puberty in girls. Hum Reprod. 2000;15:1052-1057. (Pubitemid 30251298)
13. Sehested A, Juul AA, Andersson AM, et al. Serum inhibin A and inhibin B in healthy prepubertal, pubertal and adolescent girls and adult women: relation to age, stage of puberty, menstrual cycle, follicle-stimulating hormone, luteinizing hormone, and estradiol levels. J Clin Endocrinol Metab. 2000;85:1634-1640. (Pubitemid 32289511)
14. Von Eckardstein S, Simoni M, Bergmann M, et al. Serum inhibin B in combination with serum FSH is a more sensitive marker than serum FSH alone for impaired spermatogenesis in men, but cannot predict the presence of sperm in testicular tissue samples. J Clin Endocrinol Metab. 1999;84:2496-2501.
15. Sempé M, Pedrón G, Roy Pernot MP. Auxologie: Methode Et Séquences. Paris, France: Théreplix; 1979.
16. Tanner JM, Whitehouse RH. Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child. 1976;51:170-179.
17. World Health Organization. WHO Manual for the Standardized Investigation, Diagnosis and Management of the Infertile Male. Cambridge, MA: Cambridge University Press; 2000.
18. Martín Ibáñez I, Curcoy Barcenilla AI, Trenchs Sainz de la Maza V, et al. Evolución de la concentración sérica de inhibina B en niños y niñas sanos a lo largo de su adolescencia: relación con estadio puberal, FSH, LH, testosterona y estradiol. Quim Clin. 2006;25:410-415.
19. Gurney JG, Kadan-Lottick NS, Packer RJ, et al. Endocrine and cardiovascular late effects among adult survivors of childhood brain tumors. Childhood Cancer Survivor Study. Cancer. 2003;97:663-673. (Pubitemid 36125844)
20. Byrne J, Fears TR, Mills JL, et al. Fertility of long-term male survivors of acute lymphoblastic leukaemia diagnosed during childhood. Pediatr Blood Cancer. 2004;42:364-372. (Pubitemid 38327632)
21. Kenney LB, Laufer MR, Grant FD, et al. High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood. Cancer. 2001;91:613-621.
22. Cicognani A, Cacciari E, Pasini A, et al. Low serum inhibin B levels as a marker of testicular damage after treatment for a childhood malignancy. Eur J Pediatr. 2000;159:103-107. (Pubitemid 30120138)
23. Bath LE, Wallace WHB, Shaw MP, et al. Depletion of ovarian reserve in young women after treatment for cancer in childhood: detection by anti- Müllerian hormone, inhibin B and ovarian ultrasound. Hum Reprod. 2003; 18:2368-2374.
24. Larsen EC, Müller J, Schmiegelow K, et al. Reduced ovarian function in long-term survivors of radiation- and chemotherapy-treated childhood cancer. J Clin Endocrinol Metab. 2003;88:5307-5314. (Pubitemid 37452732)
25. Soriano Guillén L, Muñoz Calvo MT, Pozo Román J, et al. Alteraciones en la función gonadal en varones pospuberales supervivientes de leucemia linfoblástica aguda y enfermedad de Hodgkin. An Esp Pediatr. 2000;53:318-323.
26. Chatterjee R, Mills W, Katz M, et al. Prospective study of pituitarygonadal function to evaluate short-term effects of ablative chemotherapy or total body irradiation with autologous or allogenic marrow transplantation in post-menarcheal female patients. Bone Marrow Transplant. 1994;13:511-517. (Pubitemid 24141175)
27. López Andreu JA, Fernández PJ, Ferrís i Tortajada J, et al. Persistent altered spermatogenesis in long-term childhood cancer survivors. Pediatr Hematol Oncol. 2000;16:21-30.
28. Couto-Silva AC, Trivin C, Thibaud E, et al. Factors affecting gonadal function after bone marrow transplantation during childhood. Bone Marrow Transplant. 2001;28:67-75. (Pubitemid 32707620)
29. Lähteenmäki PM, Toppari J, Ruokonen A, et al. Low serum inhibin B concentrations in male survivors of childhood malignancy. Eur J Cancer. 1999;35:612-619. (Pubitemid 29192971)
30. Crofton PM, Thomson AB, Evans AE, et al. Is inhibin B a potential marker of gonadotoxicity in prepubertal children treated for cancer? Clin Endocrinol (Oxf). 2003;58:296-301.
31. Blatt J, Poplack DG, Sherins RJ. Testicular function in boys after chemotherapy for acute lymphoblastic leukaemia. N Engl J Med. 1981;304:1121-1124. (Pubitemid 11099206)
32. Shalet SM, Hann IM, Lendon M, et al. Testicular function after combination chemotherapy in childhood for acute lymphoblastic leukaemia. Arch Dis Child. 1981;56:275-278. (Pubitemid 11113240)
33. Wallace WHB, Anderson RA, Irvine DS. Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol. 2005;6:209-218.
34. Pal L, Leykin L, Schifren JL, et al. Malignancy may adversely influence the quality and behaviour of oocytes. Hum Reprod. 1998;13:1837-1840. (Pubitemid 28393465)
35. Wallace EM, Groome NP, Riley SC, et al. Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study. J Clin Endocrinol Metab. 1997;82:3111-3115.
36. Quigley C, Cowell C, Jimenez M, et al. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia. N Engl J Med. 1989;321:143-151. (Pubitemid 19180677)
37. Pierik FH, Vreeburg JT, Stijnen T, et al. Serum inhibin B as a marker of spermatogenesis. J Clin Endocrinol Metab. 1998;83:3110-3114.
38. Lockwood G. The diagnostic value of inhibin in infertility evaluation. Semin Reprod Med. 2004;22:195-208. (Pubitemid 39122125)
39. Lutchman Singh K, Davies M, Chatterjee R. Fertility in female cancer survivors: pathophysiology, preservation and the role of ovarian reserve testing. Hum Reprod Update. 2005;11:69-89. (Pubitemid 40201977)
40. Welt CK, Hall JE, Adams JM, et al. Relationship of estradiol and inhibin to the FSH variability in hypergonadotropic hypogonadism or premature ovarian failure. J Clin Endocrinol Metab. 2005;90:826-830.
41. Byrne J. Infertility and premature menopause in childhood cancer survivors. Med Pediatr Oncol. 1999;33:24-28. (Pubitemid 29318660)